Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > U of Alberta & Drs. Lilge & McFarland Paper Now Available

<< Previous

Bullboard Posts

Next >>

Comment by Camphikefishon Aug 28, 2023 2:01pm

215 Views

Post# 35608459

RE:U of Alberta & Drs. Lilge & McFarland Paper Now Available

As of June 2023 Astellas Pharma has $4.16 Billion Cash on Hand. For what it's worth. 1433 looks like a very fitting dovetail into their product portfolio. Also seems some combo potential with their existing drug(s) are a very viable option. Who knows.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)